Abstract
The increase in resistance to conventional antimicrobials in recent years has boosted the search for new antibiotics to treat serious infectious diseases, especially those generated by multi-resistant bacteria. In this context, antimicrobial peptides (AMPs) are alternative molecules for use as new therapeutic agents. AMPs are small bioactive proteins commonly produced by all living organisms, and they can be part of innate immunity. Due to their broad-spectrum antibacterial potential and other activities, including immunomodulatory and antitumor, they are of great interest to the pharmaceutical industry’s production of biopharmaceuticals. Among the technological platforms applied in the process of development and manufacturing of AMPs, recombinant DNA technology has enabled the production of such molecules using bacterial and yeast cells as expression host systems on a laboratory scale and in large-scale environments. Furthermore, different bioprocessing strategies can be used for peptide industrial production, aiming to optimize the yield, make cultures more robust and significantly increase cell density. In this chapter, we will address recent developments and future directions in AMPs bioprocessing, including microbial expression systems, as well as bioprocessing and purification technologies. Here we also describe successful cases in this field and emphasize the prospects and challenges related to AMPs bioengineering.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abbas A, Plattner S, Shah KH, Bohlmann H (2013) Comparison of periplasmic and intracellular expression of Arabidopsis thionin proproteins in E. coli. Biotechnol Lett 35:1085–1091
Agbale CM, Sarfo JK, Galyuon IK et al (2019) Antimicrobial and antibiofilm activities of helical antimicrobial peptide sequences incorporating metal-binding motifs. Biochemistry 58:3802–3812
Agyei D, Ahmed I, Akram Z et al (2017) Protein and peptide biopharmaceuticals: an overview. Protein Pept Lett 24:94–101
Ahmad M, Hirz M, Pichler H, Schwab H (2014) Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production. Appl Microbiol Biotechnol 98:5301–5317
Ahmad I, Nawaz N, Darwesh NM et al (2018) Overcoming challenges for amplified expression of recombinant proteins using Escherichia coli. Protein Expr Purif 144:12–18
Ahmad B, Hanif Q, Xubiao W et al (2019) Expression and purification of hybrid ll-37tα1 peptide in Pichia pastoris and evaluation of its immunomodulatory and anti-inflammatory activities by LPS neutralization. Front Immunol 10:1–12
Almaaytah A, Qaoud MT, Abualhaijaa A et al (2018) Hybridization and antibiotic synergism as a tool for reducing the cytotoxicity of antimicrobial peptides. Infect Drug Resist 11:835–847
Almeida LHO, de Oliveira CFR, Rodrigues MS et al (2020) Adepamycin: design, synthesis and biological properties of a new peptide with antimicrobial properties. Arch Biochem Biophys 691:108487
Andersson DI, Hughes D, Kubicek-Sutherland JZ (2016) Mechanisms and consequences of bacterial resistance to antimicrobial peptides. Drug Resist Updat 26:43–57
Arbulu S, Jiménez JJ, Gútiez L et al (2019) Cloning and expression of synthetic genes encoding native, hybrid- and bacteriocin-derived chimeras from mature class IIa bacteriocins, by Pichia pastoris (syn. Komagataella spp.). Food Res Int 121:888–899
Arora S, Saxena V, Ayyar BV (2017) Affinity chromatography: a versatile technique for antibody purification. Methods 116:84–94
Ashcheulova DO, Efimova LV, Lushchyk AY et al (2018) Production of the recombinant antimicrobial peptide UBI 18-35 in Escherichia coli. Protein Expr Purif 143:38–44
Assis LM, Nedeljković M, Dessen A (2017) New strategies for targeting and treatment of multi-drug resistant Staphylococcus aureus. Drug Resist Updat 31:1–14
Azari M, Asad S, Mehrnia MR (2020) Heterologous production of porcine derived antimicrobial peptide PR-39 in Escherichia coli using SUMO and intein fusion systems. Protein Expr Purif 169:105568
Basanta A, Gómez-Sala B, Sánchez J et al (2010) Use of the yeast Pichia pastoris as an expression host for secretion of enterocin L50, a leaderless two-peptide (L50A and L50B) bacteriocin from Enterococcus faecium L50▽. Appl Environ Microbiol 76:3314–3324
Beaulieu L, Tolkatchev D, Jetté JF et al (2007) Production of active pediocin PA-1 in Escherichia coli using a thioredoxin gene fusion expression approach: cloning, expression, purification, and characterization. Can J Microbiol 53:1246–1258
Belguesmia Y, Bendjeddou K, Kempf I et al (2020) Heterologous biosynthesis of five new class II bacteriocins from Lactobacillus paracasei CNCM I-5369 with antagonistic activity against pathogenic Escherichia coli strains. Front Microbiol 11:1–9
Bhambure R, Kumar K, Rathore AS (2011) High-throughput process development for biopharmaceutical drug substances. Trends Biotechnol 29:127–135. https://doi.org/10.1016/j.tibtech.2010.12.001
Bhopale GM (2020) Antimicrobial peptides: a promising avenue for human healthcare. Curr Pharm Biotechnol 21:90–96
Blunt W, Levin DB, Cicek N (2018) Bioreactor operating strategies for improved polyhydroxyalkanoate (PHA) productivity. Polymers (Basel) 10:1197
Bommarius B, Jenssen H, Elliott M et al (2010) Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli. Peptides 31:1957–1965
Boparai JK, Sharma PK (2019) Mini review on antimicrobial peptides, sources, mechanism and recent applications. Protein Pept Lett 27:4–16
Boto A, Pérez de la Lastra J, González C (2018) The road from host-defense peptides to a new generation of antimicrobial drugs. Molecules 23:311
Briand L, Marcion G, Kriznik A et al (2016) A self-inducible heterologous protein expression system in Escherichia coli. Sci Rep 6:33037
Browne K, Chakraborty S, Chen R et al (2020) A new era of antibiotics: the clinical potential of antimicrobial peptides. Int J Mol Sci 21:7047
Butt TR, Edavettal SC, Hall JP, Mattern MR (2005) SUMO fusion technology for difficult-to-express proteins. Protein Expr Purif 43:1–9
Cardoso P, Glossop H, Meikle TG et al (2021) Molecular engineering of antimicrobial peptides: microbial targets, peptide motifs and translation opportunities. Biophys Rev 13:35–69
Carta G, Jungbauer A (2010) Protein chromatography. Wiley, Chichester
Chen CH, Lu TK (2020) Development and challenges of antimicrobial peptides for therapeutic applications. Antibiotics 9:24
Cheng KT, Wu CL, Yip BS et al (2018) High level expression and purification of the clinically active antimicrobial peptide P-113 in Escherichia coli. Molecules 23:800
Chu C, Zhang W, Li J et al (2018) A single codon optimization enhances recombinant human TNF-α vaccine expression in Escherichia coli. Biomed Res Int 2018:1–8
Chung BKS, Lee DY (2012) Computational codon optimization of synthetic gene for protein expression. BMC Syst Biol 6:134
Clarke KG (2013) Downstream processing. In: Bioprocess engineering. Elsevier, Amsterdam, pp 209–234
Corrales-García LL, Serrano-Carreón L, Corzo G (2020) Improving the heterologous expression of human β-defensin 2 (HBD2) using an experimental design. Protein Expr Purif 167:105539
Costa Ramos LF, Rangel J, Andrade G et al (2021) Identification and recombinant expression of an antimicrobial peptide (cecropin B-like) from soybean pest Anticarsia gemmatalis. J Venom Anim Toxins Incl Trop Dis 27:1–12
Costa S, Almeida A, Castro A, Domingues L (2014) Fusion tags for protein solubility, purification and immunogenicity in Escherichia coli: the novel Fh8 system. Front Microbiol 5:1–20
Cui W, Han L, Suo F et al (2018) Exploitation of Bacillus subtilis as a robust workhorse for production of heterologous proteins and beyond. World J Microbiol Biotechnol 34:145
D’Anjou MC, Daugulis AJ (2000) Mixed-feed exponential feeding for fed-batch culture of recombinant methylotrophic yeast. Biotechnol Lett 22:341–346
da Costa JP, Cova M, Ferreira R, Vitorino R (2015) Antimicrobial peptides: an alternative for innovative medicines? Appl Microbiol Biotechnol 99:2023–2040
Daly R, Hearn MTW (2005) Expression of heterologous proteins in Pichia pastoris: a useful experimental tool in protein engineering and production. J Mol Recognit 18:119–138
Dauer K, Pfeiffer-Marek S, Kamm W, Wagner KG (2021) Microwell plate-based dynamic light scattering as a high-throughput characterization tool in biopharmaceutical development. Pharmaceutics 13:172
de Oliveira KBS, Leite ML, Rodrigues GR et al (2020) Strategies for recombinant production of antimicrobial peptides with pharmacological potential. Expert Rev Clin Pharmacol 13:367–390
de Paiva DP, Rocha TB, Rubini MR et al (2018) A study on the use of strain-specific and homologous promoters for heterologous expression in industrial Saccharomyces cerevisiae strains. AMB Express 8:82
Deng T, Ge H, He H et al (2017) The heterologous expression strategies of antimicrobial peptides in microbial systems. Protein Expr Purif 140:52–59
Diers IV, Rasmussen E, Larsen PH, Kjaersig I (1991) Yeast fermentation processes for insulin production. Bioprocess Technol 13:166–176
Dijksteel GS, Ulrich MMW, Middelkoop E, Boekema BKHL (2021) Review: lessons learned from clinical trials using antimicrobial peptides (AMPs). Front Microbiol 12:616979
Drayton M, Kizhakkedathu JN, Straus SK (2020) Towards robust delivery of antimicrobial peptides to combat bacterial resistance. Molecules 25:3048
Ehgartner D, Sagmeister P, Langemann T et al (2017) A novel method to recover inclusion body protein from recombinant E. coli fed-batch processes based on phage ΦX174-derived lysis protein E. Appl Microbiol Biotechnol 101:5603–5614
Feng X, Xu W, Qu P et al (2015) High-yield recombinant expression of the chicken antimicrobial peptide fowlicidin-2 in Escherichia coli. Biotechnol Prog 31:369–374
Fensterseifer ICM, Felício MR, Alves ESF et al (2019) Selective antibacterial activity of the cationic peptide PaDBS1R6 against Gram-negative bacteria. Biochim Biophys Acta Biomembr 1861:1375–1387
Fida HM, Kumada Y, Terashima M et al (2009) Tandem multimer expression of angiotensin I-converting enzyme inhibitory peptide in Escherichia coli. Biotechnol J 4:1345–1356
Franco OL (2011) Peptide promiscuity: an evolutionary concept for plant defense. FEBS Lett 585:995–1000
Fu H, Liang Y, Zhong X et al (2020) Codon optimization with deep learning to enhance protein expression. Sci Rep 10:17617
García-Ortega X, Cámara E, Ferrer P et al (2019) Rational development of bioprocess engineering strategies for recombinant protein production in Pichia pastoris (Komagataella phaffii) using the methanol-free GAP promoter. Where do we stand? New Biotechnol 53:24–34
Ge Y, MacDonald DL, Holroyd KJ et al (1999) In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob Agents Chemother 43:782–788
Gomes AR, Byregowda SM, Veeregowda BM, Balamurugan V (2016) An overview of heterologous expression host systems for the production of recombinant proteins. Adv Anim Vet Sci 4:346–356
Gronemeyer P, Ditz R, Strube J (2014) Trends in upstream and downstream process development for antibody manufacturing. Bioengineering 1:188–212
Gupta SK, Shukla P (2017) Sophisticated cloning, fermentation, and purification technologies for an enhanced therapeutic protein production: a review. Front Pharmacol 8:1–17
Haney EF, Mansour SC, Hancock REW (2017) Antimicrobial peptides. Springer, New York
Hanson G, Coller J (2018) Codon optimality, bias and usage in translation and mRNA decay. Nat Rev Mol Cell Biol 19:20–30
He Q, Fu A, Li T (2015) Expression and one-step purification of the antimicrobial peptide cathelicidin-BF using the intein system in Bacillus subtilis. J Ind Microbiol Biotechnol 42:647–653
Hebbi V, Kumar D, Rathore AS (2020) Process analytical technology implementation for peptide manufacturing: cleavage reaction of recombinant lethal toxin neutralizing factor concatemer as a case study. Anal Chem 92:5676–5681
Jiang R, Zhang P, Wu X et al (2021) Expression of antimicrobial peptide Cecropin P1 in Saccharomyces cerevisiae and its antibacterial and antiviral activity in vitro. Electron J Biotechnol 50:16–22
Jin F, Xu X, Wang L et al (2006) Expression of recombinant hybrid peptide cecropinA(1–8)–magainin2(1–12) in Pichia pastoris: purification and characterization. Protein Expr Purif 50:147–156
Jozala AF, Geraldes DC, Tundisi LL et al (2016) Biopharmaceuticals from microorganisms: from production to purification. Braz J Microbiol 47:51–63
Judzewitsch PR, Corrigan N, Trujillo F, et al (2020) High-throughput process for the discovery of antimicrobial polymers and their upscaled production via flow polymerization. Macromolecules 53:631–639. https://doi.org/10.1021/acs.macromol.9b02207
Juturu V, Wu JC (2018) Heterologous protein expression in Pichia pastoris: latest research progress and applications. Chembiochem 19:7–21
Kasemiire A, Avohou HT, De Bleye C et al (2021) Design of experiments and design space approaches in the pharmaceutical bioprocess optimization. Eur J Pharm Biopharm 166:144–154
Kaur J, Kumar A, Kaur J (2018) Strategies for optimization of heterologous protein expression in E. coli: roadblocks and reinforcements. Int J Biol Macromol 106:803–822
Kaur N, Dilawari R, Kaur A et al (2020) Recombinant expression, purification and PEGylation of Paneth cell peptide (cryptdin-2) with value added attributes against Staphylococcus aureus. Sci Rep 10:12164
Khanal O, Lenhoff AM (2021) Developments and opportunities in continuous biopharmaceutical manufacturing. MAbs 13:1903664
Khow O, Suntrarachun S (2012) Strategies for production of active eukaryotic proteins in bacterial expression system. Asian Pac J Trop Biomed 2:159–162
Kimple ME, Brill AL, Pasker RL (2013) Overview of affinity tags for protein purification. Curr Protoc Protein Sci 73:9.9.1–9.9.23
Klubthawee N, Adisakwattana P, Hanpithakpong W et al (2020) A novel, rationally designed, hybrid antimicrobial peptide, inspired by cathelicidin and aurein, exhibits membrane-active mechanisms against Pseudomonas aeruginosa. Sci Rep 10:9117
Koller M (2018) A review on established and emerging fermentation schemes for microbial production of polyhydroxyalkanoate (PHA) biopolyesters. Fermentation 4:1–30
Koo HB, Seo J (2019) Antimicrobial peptides under clinical investigation. Pept Sci 111:1–15
Kornecki M, Strube J (2018) Process analytical technology for advanced process control in biologics manufacturing with the aid of macroscopic kinetic modeling. Bioengineering 5:25
Kumar P, Kizhakkedathu J, Straus S (2018) Antimicrobial peptides: diversity, mechanism of action and strategies to improve the activity and biocompatibility in vivo. Biomol Ther 8:4
Lanza AM, Curran KA, Rey LG, Alper HS (2014) A condition-specific codon optimization approach for improved heterologous gene expression in Saccharomyces cerevisiae. BMC Syst Biol 8:33
LaVallie ER, DiBlasio EA, Kovacic S et al (1993) A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm. Bio/Technology 11:187–193
Laws M, Shaaban A, Rahman KM (2019) Antibiotic resistance breakers: current approaches and future directions. FEMS Microbiol Rev 43:490–516
Lee J, Kim M, Cho J, Kim S (2002) Enhanced expression of tandem multimers of the antimicrobial peptide buforin II in Escherichia coli by the DEAD-box protein and trxB mutant. Appl Microbiol Biotechnol 58:790–796
Lee EY, Lee MW, Fulan BM et al (2017) What can machine learning do for antimicrobial peptides, and what can antimicrobial peptides do for machine learning? Interface Focus 7:20160153
Leite ML, Sampaio KB, Costa FF et al (2019) Molecular farming of antimicrobial peptides: available platforms and strategies for improving protein biosynthesis using modified virus vectors. An Acad Bras Cienc 91:1–23
León-Buitimea A, Garza-Cárdenas CR, Garza-Cervantes JA et al (2020) The demand for new antibiotics: antimicrobial peptides, nanoparticles, and combinatorial therapies as future strategies in antibacterial agent design. Front Microbiol 11:1–10
Li Y (2011) Recombinant production of antimicrobial peptides in Escherichia coli: a review. Protein Expr Purif 80:260–267
Li T, Bin CX, Chen JC et al (2014a) Open and continuous fermentation: products, conditions and bioprocess economy. Biotechnol J 9:1503–1511
Li Y, Wang J, Yang J et al (2014b) Recombinant expression, purification and characterization of antimicrobial peptide ORBK in Escherichia coli. Protein Expr Purif 95:182–187
Li L, Mu L, Wang X et al (2017) A novel expression vector for the secretion of abaecin in Bacillus subtilis. Braz J Microbiol 48:809–814
Li H, Ali Z, Liu X et al (2019) Expression of recombinant tachyplesin I in Pichia pastoris. Protein Expr Purif 157:50–56
Li Z, Cheng Q, Guo H et al (2020) Expression of hybrid peptide EF-1 in Pichia pastoris, its purification, and antimicrobial characterization. Molecules 25:5538
Liang W, Diana J (2020) The dual role of antimicrobial peptides in autoimmunity. Front Immunol 11:1–9
Lima SMF, Freire MS, Gomes ALO et al (2017) Antimicrobial and immunomodulatory activity of host defense peptides, clavanins and LL-37, in vitro: an endodontic perspective. Peptides 95:16–24
Lin Q, Xie K, Chen D et al (2020) Expression and functional characterization of a novel antimicrobial peptide: human beta-defensin 118. Biomed Res Int 2020:1–10
Liscano Y, Oñate-Garzón J, Delgado JP (2020) Peptides with dual antimicrobial–anticancer activity: strategies to overcome peptide limitations and rational design of anticancer peptides. Molecules 25:4245
Liu SN, Han Y, Zhou ZJ (2011) Fusion expression of pedA gene to obtain biologically active pediocin PA-1 in Escherichia coli. J Zhejiang Univ Sci B 12:65–71
Liu H, Yang N, Mao R et al (2020) A new high-yielding antimicrobial peptide NZX and its antibacterial activity against Staphylococcus hyicus in vitro/vivo. Appl Microbiol Biotechnol 104:1555–1568
Lombardi L, Shi Y, Falanga A et al (2019) Enhancing the potency of antimicrobial peptides through molecular engineering and self-assembly. Biomacromolecules 20:1362–1374
Looser V, Bruhlmann B, Bumbak F et al (2015) Cultivation strategies to enhance productivity of Pichia pastoris: a review. Biotechnol Adv 33:1177–1193
Love KR, Dalvie NC, Love JC (2018) The yeast stands alone: the future of protein biologic production. Curr Opin Biotechnol 53:50–58
Mahlapuu M, Björn C, Ekblom J (2020) Antimicrobial peptides as therapeutic agents: opportunities and challenges. Crit Rev Biotechnol 40:978–992
Mauro VP, Chappell SA (2014) A critical analysis of codon optimization in human therapeutics. Trends Mol Med 20:604–613
Mayr LM, Bojanic D (2009) Novel trends in high-throughput screening. Curr Opin Pharmacol 9:580–588
Mears L, Stocks SM, Sin G, Gernaey KV (2017) A review of control strategies for manipulating the feed rate in fed-batch fermentation processes. J Biotechnol 245:34–46
Meng DM, Lv YJ, Zhao JF et al (2018) Efficient production of a recombinant Venerupis philippinarum defensin (VpDef) in Pichia pastoris and characterization of its antibacterial activity and stability. Protein Expr Purif 147:78–84
Meng D-M, Li W-J, Shi L-Y et al (2019) Expression, purification and characterization of a recombinant antimicrobial peptide Hispidalin in Pichia pastoris. Protein Expr Purif 160:19–27
Mercer DK, Torres MDT, Duay SS et al (2020) Antimicrobial susceptibility testing of antimicrobial peptides to better predict efficacy. Front Cell Infect Microbiol 10:1–34
Mirski T, Niemcewicz M, Bartoszcze M et al (2017) Utilisation of peptides against microbial infections—a review. Ann Agric Environ Med 25:205–210
Mishra B, Reiling S, Zarena D, Wang G (2017) Host defense antimicrobial peptides as antibiotics: design and application strategies. Curr Opin Chem Biol 38:87–96
Møller TSB, Hay J, Saxton MJ et al (2017) Human β-defensin-2 production from S. cerevisiae using the repressible MET17 promoter. Microb Cell Factories 16:11
Moravej H, Moravej Z, Yazdanparast M et al (2018) Antimicrobial peptides: features, action, and their resistance mechanisms in bacteria. Microb Drug Resist 24:747–767
Moretta A, Salvia R, Scieuzo C et al (2020) A bioinformatic study of antimicrobial peptides identified in the Black Soldier Fly (BSF) Hermetia illucens (Diptera: Stratiomyidae). Sci Rep 10:16875
Moretta A, Scieuzo C, Petrone AM et al (2021) Antimicrobial peptides: a new hope in biomedical and pharmaceutical fields. Front Cell Infect Microbiol 11:1–26
Mulder KC, de Lima LA, Aguiar PS et al (2015) Production of a modified peptide clavanin in Pichia pastoris: cloning, expression, purification and in vitro activities. AMB Express 5:46
Naumov GI, Naumova ES, Boundy-Mills KL (2018) Description of Komagataella mondaviorum sp. nov., a new sibling species of Komagataella (Pichia) pastoris. Antonie van Leeuwenhoek 111:1197–1207
Nguyen LT, Haney EF, Vogel HJ (2011) The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol 29:464–472
Öztürk S, Ergün BG, Çalık P (2017) Double promoter expression systems for recombinant protein production by industrial microorganisms. Appl Microbiol Biotechnol 101:7459–7475
Pal G, Srivastava S (2015) Scaling up the production of recombinant antimicrobial Plantaricin E from a heterologous host, Escherichia coli. Probiotics Antimicrob Proteins 7:216–221
Pan X, Yang Y, Liu X et al (2016) Secretory expression of a heterologous protein, Aiio-AIO6BS, in Bacillus subtilis via a non-classical secretion pathway. Biochem Biophys Res Commun 478:881–886
Parachin NS, Mulder KC, Viana AAB et al (2012) Expression systems for heterologous production of antimicrobial peptides. Peptides 38:446–456
Peebo K, Neubauer P (2018) Application of continuous culture methods to recombinant protein production in microorganisms. Microorganisms 6:56
Philip P, Meier K, Kern D et al (2017) Systematic evaluation of characteristics of the membrane-based fed-batch shake flask. Microb Cell Factories 16:122
Pieracci JP, Armando JW, Westoby M, Thommes J (2018) Industry review of cell separation and product harvesting methods. In: Biopharmaceutical processing. Elsevier, Amsterdam, pp 165–206
Potvin G, Ahmad A, Zhang Z (2012) Bioprocess engineering aspects of heterologous protein production in Pichia pastoris: a review. Biochem Eng J 64:91–105
Presnyak V, Alhusaini N, Chen YH et al (2015) Codon optimality is a major determinant of mRNA stability. Cell 160:1111–1124
Quinn GA, Maloy AP, McClean S et al (2012) Lipopeptide biosurfactants from Paenibacillus polymyxa inhibit single and mixed species biofilms. Biofouling 28:1151–1166
Raja Z, André S, Abbassi F et al (2017) Insight into the mechanism of action of temporin-SHa, a new broad-spectrum antiparasitic and antibacterial agent. PLoS One 12:e0174024
Ramirez LS, Pande J, Shekhtman A (2019) Helical structure of recombinant melittin. J Phys Chem B 123:356–368
Rathore AS, Agarwal H, Sharma AK et al (2015) Continuous processing for production of biopharmaceuticals. Prep Biochem Biotechnol 45:836–849
Rios AC, Moutinho CG, Pinto FC et al (2016) Alternatives to overcoming bacterial resistances: state-of-the-art. Microbiol Res 191:51–80
Rosano GL, Ceccarelli EA (2014) Recombinant protein expression in Escherichia coli: advances and challenges. Front Microbiol 5:1–17
Rosano GL, Morales ES, Ceccarelli EA (2019) New tools for recombinant protein production in Escherichia coli: a 5-year update. Protein Sci 28:1412–1422
Sang M, Wei H, Zhang J et al (2017) Expression and characterization of the antimicrobial peptide ABP-dHC-cecropin A in the methylotrophic yeast Pichia pastoris. Protein Expr Purif 140:44–51
São Pedro MN, Silva TC, Patil R, Ottens M (2021) White paper on high-throughput process development for integrated continuous biomanufacturing. Biotechnol Bioeng 118:3275–3286
Schuller A, Cserjan-Puschmann M, Tauer C et al (2020) Escherichia coli σ70 promoters allow expression rate control at the cellular level in genome-integrated expression systems. Microb Cell Factories 19:58
Scott B, Wilcock A (2006) Process analytical technology in the pharmaceutical industry: a toolkit for continuous improvement. PDA J Pharm Sci Technol 60:17–53
Sen A, Kargar K, Akgün E, Plnar MC (2020) Codon optimization: a mathematical programing approach. Bioinformatics 36:4012–4020
Seyfi R, Kahaki FA, Ebrahimi T et al (2020) Antimicrobial peptides (AMPs): roles, functions and mechanism of action. Int J Pept Res Ther 26:1451–1463
Sezonov G, Joseleau-Petit D, D’Ari R (2007) Escherichia coli physiology in Luria-Bertani Broth. J Bacteriol 189:8746–8749
Shukla AA, Rameez S, Wolfe LS, Oien N (2017) High-throughput process development for biopharmaceuticals. In: Advances in biochemical engineering/biotechnology. Springer Nature, Berlin, pp 401–441
Silva ON, Mulder KCL, Barbosa AEAD et al (2011) Exploring the pharmacological potential of promiscuous host-defense peptides: from natural screenings to biotechnological applications. Front Microbiol 2:1–14
Silva TC, Eppink M, Ottens M (2021) Automation and miniaturization: enabling tools for fast, high-throughput process development in integrated continuous biomanufacturing. J Chem Technol Biotechnol jctb6792
Singh N, Pizzelli K, Romero JK et al (2013) Clarification of recombinant proteins from high cell density mammalian cell culture systems using new improved depth filters. Biotechnol Bioeng 110:1964–1972
Sinha R, Shukla P (2019) Antimicrobial peptides: recent insights on biotechnological interventions and future perspectives. Protein Pept Lett 26:79–87
Sousa DA, Mulder KCL, Nobre KS et al (2016) Production of a polar fish antimicrobial peptide in Escherichia coli using an ELP-intein tag. J Biotechnol 234:83–89
Taneda A, Asai K (2020) COSMO: a dynamic programming algorithm for multicriteria codon optimization. Comput Struct Biotechnol J 18:1811–1818
Tang X-S, Shao H, Li T-J et al (2012) Dietary supplementation with bovine lactoferrampin–lactoferricin produced by Pichia pastoris fed-batch fermentation affects intestinal microflora in weaned piglets. Appl Biochem Biotechnol 168:887–898
Tavares LS, Rettore JV, Freitas RM et al (2012) Antimicrobial activity of recombinant Pg-AMP1, a glycine-rich peptide from guava seeds. Peptides 37:294–300
Terpe K (2006) Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems. Appl Microbiol Biotechnol 72:211–222
Thapa RK, Diep DB, Tønnesen HH (2020) Topical antimicrobial peptide formulations for wound healing: current developments and future prospects. Acta Biomater 103:52–67
Tian ZG, Teng D, Yang YL et al (2007) Multimerization and fusion expression of bovine lactoferricin derivative LfcinB15-W4,10 in Escherichia coli. Appl Microbiol Biotechnol 75:117–124
Tian J, Yan Y, Yue Q et al (2017) Predicting synonymous codon usage and optimizing the heterologous gene for expression in E. coli. Sci Rep 7:9926
Tian L, Zhang D, Su P et al (2019) Design, recombinant expression, and antibacterial activity of a novel hybrid magainin–thanatin antimicrobial peptide. Prep Biochem Biotechnol 49:427–434
Tornesello AL, Borrelli A, Buonaguro L et al (2020) Antimicrobial peptides as anticancer agents: functional properties and biological activities. Molecules 25:2850
Tripathi NK, Shrivastava A (2019) Recent developments in bioprocessing of recombinant proteins: expression hosts and process development. Front Bioeng Biotechnol 7:1–35
Viel JH, Jaarsma AH, Kuipers OP (2021) Heterologous expression of mersacidin in Escherichia coli elucidates the mode of leader processing. ACS Synth Biol 10:600–608
Vilas Boas LCP, de Lima LMP, Migliolo L et al (2017) Linear antimicrobial peptides with activity against herpes simplex virus 1 and Aichi virus. Pept Sci 108:e22871
Vogt CM, Schraner EM, Aguilar C, Eichwald C (2016) Heterologous expression of antigenic peptides in Bacillus subtilis biofilms. Microb Cell Factories 15:137
Wade HM, Darling LEO, Elmore DE (2019) Hybrids made from antimicrobial peptides with different mechanisms of action show enhanced membrane permeabilization. Biochim Biophys Acta Biomembr 1861:182980
Wang A, Wang S, Shen M et al (2009) High level expression and purification of bioactive human α-defensin 5 mature peptide in Pichia pastoris. Appl Microbiol Biotechnol 84:877–884
Wang FJ, Song HL, Wang XM et al (2012) Tandem multimer expression and preparation of hypoglycemic peptide MC6 from Momordica charantia in Escherichia coli. Appl Biochem Biotechnol 166:612–619
Wang J, Dou X, Song J et al (2019) Antimicrobial peptides: promising alternatives in the post feeding antibiotic era. Med Res Rev 39:831–859
Weinacker D, Rabert C, Zepeda AB et al (2013) Applications of recombinant Pichia pastoris in the healthcare industry. Braz J Microbiol 44:1043–1048
Whitesides GM (2006) The origins and the future of microfluidics. Nature 442:368–373
Wibowo D, Zhao C-X (2019) Recent achievements and perspectives for large-scale recombinant production of antimicrobial peptides. Appl Microbiol Biotechnol 103:659–671
Wu R, Wang Q, Zheng Z et al (2014) Design, characterization and expression of a novel hybrid peptides melittin (1-13)-LL37 (17-30). Mol Biol Rep 41:4163–4169
Xiao S, Gao Y, Wang X et al (2017) Peroxisome-targeted and tandem repeat multimer expressions of human antimicrobial peptide LL37 in Pichia pastoris. Prep Biochem Biotechnol 47:229–235
Xu X, Jin F, Yu X et al (2007) High-level expression of the recombinant hybrid peptide cecropinA(1-8)-magainin2(1-12) with an ubiquitin fusion partner in Escherichia coli. Protein Expr Purif 55:175–182
Yang N, Teng D, Mao R et al (2019) A recombinant fungal defensin-like peptide-P2 combats multidrug-resistant Staphylococcus aureus and biofilms. Appl Microbiol Biotechnol 103:5193–5213
Yang Y, Wu D, Wang C et al (2020) Hybridization with insect cecropin a (1–8) improve the stability and selectivity of naturally occurring peptides. Int J Mol Sci 21:1470
Ÿztürk S, Ÿalık P, Ÿzdamar TH (2016) Fed-batch biomolecule production by Bacillus subtilis: a state of the art review. Trends Biotechnol 34:329–345
Zandsalimi F, Talaei S, Noormohammad Ahari M et al (2020) Antimicrobial peptides: a promising strategy for lung cancer drug discovery? Expert Opin Drug Discov 15:1343–1354
Zhan N, Zhang L, Yang H et al (2021) Design and heterologous expression of a novel dimeric LL37 variant in Pichia pastoris. Microb Cell Factories 20:143
Zhang J, Movahedi A, Wei Z et al (2016) High-level SUMO-mediated fusion expression of ABP-dHC-cecropin A from multiple joined genes in Escherichia coli. Anal Biochem 509:15–23
Zhang K, Su L, Duan X et al (2017) High-level extracellular protein production in Bacillus subtilis using an optimized dual-promoter expression system. Microb Cell Factories 16:32
Zhang X, Jiang A, Qi B et al (2018) Secretion expression of human neutrophil peptide 1 (HNP1) in Pichia pastoris and its functional analysis against antibiotic-resistant Helicobacter pylori. Appl Microbiol Biotechnol 102:4817–4827
Zhang L, Wei D, Zhan N et al (2020) Heterologous expression of the novel α-helical hybrid peptide PR-FO in Bacillus subtilis. Bioprocess Biosyst Eng 43:1619–1627
Zhao W, Wang J, Deng R, Wang X (2008) Scale-up fermentation of recombinant Candida rugosa lipase expressed in Pichia pastoris using the GAP promoter. J Ind Microbiol Biotechnol 35:189–195
Zhao H, Tang J, Cao L et al (2015) Characterization of bioactive recombinant antimicrobial peptide parasin I fused with human lysozyme expressed in the yeast Pichia pastoris system. Enzym Microb Technol 77:61–67
Zhou Y, Cao W, Wang J et al (2005) Comparison of expression of monomeric and multimeric adenoregulin genes in Escherichia coli and Pichia pastoris. Protein Pept Lett 12:349–355
Zhoua Z, Danga Y, Zhou M et al (2016) Codon usage is an important determinant of gene expression levels largely through its effects on transcription. Proc Natl Acad Sci U S A 113:E6117–E6125
Zobel S, Kumpfmüller J, Süssmuth RD, Schweder T (2015) Bacillus subtilis as heterologous host for the secretory production of the non-ribosomal cyclodepsipeptide enniatin. Appl Microbiol Biotechnol 99:681–691
Zydney AL (2016) Continuous downstream processing for high value biological products: a review. Biotechnol Bioeng 113:465–475
Acknowledgments
This work was supported by the Coordination of Improvement of Higher Education Personnel (CAPES); National Council of Technological and Scientific Development (CNPq), Federal District Research Support Foundation (FAPDF) and Support Foundation for the Development of Education, Science and Technology of the State of Mato Grosso do Sul (FUNDECT).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
de Oliveira, K.B.S., Leite, M.L., Rodrigues, G.R., da Cunha, N.B., Dias, S.C., Franco, O.L. (2022). Current Trends and Prospects in Antimicrobial Peptide Bioprocessing. In: Rehm, B.H.A., Wibowo, D. (eds) Microbial Production of High-Value Products. Microbiology Monographs, vol 37. Springer, Cham. https://doi.org/10.1007/978-3-031-06600-9_5
Download citation
DOI: https://doi.org/10.1007/978-3-031-06600-9_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-06599-6
Online ISBN: 978-3-031-06600-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)